Caricamento...
NKG2D CAR T cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors
Tumor heterogeneity presents a substantial barrier to increasing clinical responses mediated by targeted therapies. Broadening the immune response elicited by treatments that target a single antigen is necessary for the elimination of tumor variants that fail to express the targeted antigen. In this...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3700668/ https://ncbi.nlm.nih.gov/pubmed/23628805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/icb.2013.17 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|